New FTC pharma patent litigation report finds increase in "reverse payment" settlements based on expanded definition of "payments" *

USA - February 6 2013
With the Supreme Court set to address the validity of "reverse payment" settlements of pharmaceutical patent litigation, the FTC released a summary…

Co-authors: Pamela L. Taylor, J. Bruce McDonald, Michael H. Knight, Phillip A. Proger.

Supreme Court leaves in place Third Circuit rule welcoming challenges to foreign conduct into U.S. courts *

USA - March 23 2012
This week the U.S. Supreme Court announced it would not review a Third Circuit decision (Animal Science) that made it easier for antitrust plaintiffs to bring claims in U.S. courts for conduct occurring overseas under the Foreign Trade Antitrust Improvements Act.

Co-authors: Paula W. Render , Thomas Demitrack.

Do compounding pharmacies "live in sin"? The FDA's assertion of enforcement authority over pharmacy compounding, and two courts' efforts to bless the practice *

USA - November 1 2011
Pharmacy compounding, as the Food and Drug Administration ("FDA") explains, "is an age-old practice in which pharmacists combine … ingredients to create unique medications that meet specific needs of individual patients."

Co-authors: Jonathan Berman .

Recent U.S. cases may allow new antitrust challenges to foreign conduct *

USA - October 26 2011
Recent decisions by the Third Circuit and the Northern District of California make it easier for plaintiffs to bring claims under the Foreign Trade Antitrust Improvements Act (FTAIA). 

Co-authors: Paula W. Render , Thomas Demitrack.